We are live on ! Find out more
SGYP

Synergy Pharmaceuticals, Inc Common Stock
SGYP

Delisted

SGYP was delisted on the 7th of March, 2019.

Back to rankings

72 hedge funds and large institutions have $106M invested in Synergy Pharmaceuticals, Inc Common Stock in 2013 Q2 according to their latest regulatory filings, with 72 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

83% less call options, than puts

Call options by funds: $54K | Put options by funds: $321K

Holders
72
Holders Change
+72
Holders Change %
–
% of All Funds
2.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
72
Increased
–
Reduced
–
Closed
–
Calls
$54K
Puts
$321K
Net Calls
-$267K
Net Calls Change
-$267K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

SGYP Hedge Fund Activity: Q2 2013 in Review

72 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Synergy Pharmaceuticals, Inc Common Stock (SGYP) for Q2 2013, worth a combined $106M.

Buyers outnumbered sellers: 72 funds opened new SGYP positions and 0 closed out — a net gain of 72 holders — while 0 added to existing stakes and 0 trimmed.

  • 72 institutional investors held Synergy Pharmaceuticals, Inc Common Stock (SGYP) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $106M of Synergy Pharmaceuticals, Inc Common Stock stock for Q2 2013.
  • 72 funds opened new Synergy Pharmaceuticals, Inc Common Stock positions in Q2 2013 and 0 closed out, a net change of +72 holders.

Based on aggregated 13F filings for Q2 2013.